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Abstract
Background: A microorganism is a complex biological system able to preserve its functional features against external
perturbations and the ability of the living systems to oppose to these external perturbations is defined ‘‘robustness’’. The
antibiotic resistance, developed by different bacteria strains, is a clear example of robustness and of ability of the bacterial
system to acquire a particular functional behaviour in response to environmental changes. In this work we have modeled
the whole mechanism essential to the methicillin-resistance through a systems biology approach. The methicillin is a b-
lactamic antibiotic that act by inhibiting the penicillin-binding proteins (PBPs). These PBPs are involved in the synthesis of
peptidoglycans, essential mesh-like polymers that surround cellular enzymes and are crucial for the bacterium survival.
Methodology: The network of genes, mRNA, proteins and metabolites was created using CellDesigner program and the
data of molecular interactions are stored in Systems Biology Markup Language (SBML). To simulate the dynamic behaviour
of this biochemical network, the kinetic equations were associated with each reaction.
Conclusions: Our model simulates the mechanism of the inactivation of the PBP by methicillin, as well as the expression of
PBP2a isoform, the regulation of the SCCmec elements (SCC: staphylococcal cassette chromosome) and the synthesis of
peptidoglycan by PBP2a. The obtained results by our integrated approach show that the model describes correctly the
whole phenomenon of the methicillin resistance and is able to respond to the external perturbations in the same way of the
real cell. Therefore, this model can be useful to develop new therapeutic approaches for the methicillin control and to
understand the general mechanism regarding the cellular resistance to some antibiotics.
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Introduction
Microorganisms are able to preserve their functional features
against external perturbations. This represents often the major
impediment to discover an efficient pharmacological therapy
against human pathogens. In fact, the target of a drug is often a
specific molecular component of the microorganisms that are
easily able to develop new molecular mechanisms for neutralizing
the drug presence [1]. For example, it has been recently solved the
structure of a protein that adds a methyl group to ribosomal RNA
and confers antibiotic resistance to bacteria [2]. Therefore, it has
been defined as ‘‘robustness’’ the ability of the living systems to
oppose to external perturbations or fluctuations to preserve some
critical functional characteristics [3].
It is now known that the functional elements of a cell, i.e. genes,
RNAs, proteins, metabolites, etc, establish an integrated network
being at the basis of the regulation of cellular biochemical
pathways. This network exerts dynamically the cellular robustness
against any external perturbation for minimizing its effects on the
whole biochemical behaviour of the system. Each functional
element has to be considered as a node of a network that carries
weighed connections with the other metabolic nodes [4]. At
present, we often know in details all molecular properties of each
biochemical element as well as the biochemical relationships
existing within each ‘‘omic’’ level but we still have poor knowledge
of the biochemical laws that connect the various ‘‘omic’’ levels.
This represents an important aspect to understand how the
biological information is transmitted within the various functional
levels as well as to clarify how the cell regulates its functional
processes and how we can act on them. Some efforts have been
made to model in mathematical terms (by graphs, neural
networks, etc.) the relationships among nodes of the same
biochemical environment, i.e., relationships among genes at
genomic level, among proteins at proteomic level, among mRNA
at transcriptomic level, and so on, but few efforts have been made
to integrate the information in vertical sense, i.e., among the
different functional levels [5].
Lacking this important integration, very hardly we will be able
to understand and to model the complex biochemical behavior as
a whole [3,6], because its biological response is produced trough
the integration between the different biochemical functional levels.
The antibiotic resistance, developed by different bacteria
strains, is a clear example of robustness and of ability of the
bacterial system to acquire a particular functional behaviour in
response to environmental changes [7]. The molecular mecha-
nisms, related to each functional level of the bacterial cell against
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Therefore, we have considered this phenomenon for a modelling
of the integrated cellular response to an external perturbation. The
modelling reflects the integrated response of the bacterial cell that
through its robustness is able to cause the ‘‘emergence’’ of new
biological properties.
The first form of drug resistance was the so called ‘‘penicillin-
resistance’’, due to penicillin, an antibiotic of the beta lactamic
family. Its resistance is due to the ability of bacteria to express
beta-lactamase, an enzyme that can inactivate the drug by
hydrolysis of its beta lactamic ring [8,9]. To overcome this
phenomenon, it was necessary to develop new drugs not affected
by the same molecular mechanisms of inactivation. One of the
defining features of bacterial resistance is based on the physical
properties of cell wall representing possible barriers for attacks by
pathogens.
The methicillin being a new synthesized antibiotic (see Figure 1)
was checked against the penicillin-resistant strains with excellent
results because it is not a beta-lactamase substrate, although the
methicillin target is the same of the penicillin. In fact, both drugs
are b-lactamic antibiotics that act by inhibiting the penicillin-
binding proteins (PBPs). PBPs are involved in the synthesis of
peptidoglycans, essential mesh-like polymers that surround cellular
enzymes and are crucial for the bacterium survival.
Once the methicillin was clinically used, the patients developed
methicillin-resistant strains, as for example the methicillin-resistant
S. aureus (MRSA) strains. For these reasons, the functional use of
this drug is now reduced to few cases [10,11]. The methicillin-
PBPs interaction causes the inactivation of the normal path to
synthesize the peptidoglycan. In MRSA strains the resistance
mechanism is based on the PBP2a expression. Moreover, some
genes (mecI_GENE, mecA_GENE and mecR1_GENE) are
located on the mobile genetic elements, known as SCCmec
elements. In particular, the mecA_GENE encodes for PBP2a
when the methicillin arrives, mecR1_GENE for membrane-bound
signal transduction protein (mecR1_PROTEIN) and mecI_GENE
for a transcriptional regulator. These PBP2a isoforms present a
decrease of binding affinities for antibiotics. Therefore, PBP2a
confers resistance by contributing to the function of native PBPs
during cell wall synthesis [10,11].
Rates of invasive infections with methicillin-resistant S. aureus
(MRSA) have increased both in the hospital and in the
community. The prevalence of methicillin-resistant S. aureus
(MRSA) worldwide [12] is continuously increasing. This spread of
virulent community associated MRSA [13] is accompanied with
the emergence S. aureus and a reduced susceptibility to other
antibiotics, such as vancomycin and other glycopeptides
[13,14,15]. Vancomycin, that is the antibiotic used for MRSA
infections for the past 40 years, does not seem to be as effective
[16] due to the appearance of vancomycin-resistant S. aureus
following the emergence of vancomycin-resistant enterococcus
[17]. Moreover, it was experimentally reported that benign-
appearing skin and soft tissue infections caused by MRSA can
progress rapidly to potentially fatal diseases [18].
What is really worrying are the recent news which report of
patients that have been infected with strains of S. aureus resistant to
methicillin and vancomycin having also acquired the ability to
release cellular toxins [19]. This is raising the spectre of the worst
kind of antibiotic-resistant superbug [19]. Studies on S. aureus
conducted for determining the minimum inhibitory concentration
at microbial population level have revealed the complex response
to drug exposure [20].
Therefore, it is necessary to understand at metabolic level the
molecular dynamics that support the persistent S. aureus bacter-
emia. Several research groups have developed strategies for the
control and the treatment of MRSA infections through modeling
approaches. Brandner et al. offer a platform to undertake high-
throughput genomic and proteomic studies of S. aureus and MRSA
infection, including the molecular mechanisms involved in
transmission, virulence, immune-escape, and antibiotic resistance.
They reported the results of the entire cloning set of S. aureus
protein-encoding open reading frames (ORFs), or ORFeome [21].
Moreover, a recent work focus on the importance of different
kinetic parameters associated with the resistance mechanisms,
using a computational approach. Murphy et al. created a model
that can be used to generate quantitatively accurate predictions of
MICs for antibiotics against different strains of MRSA and to
quantify the effects of the principal pharmacokinetic parameters of
these antibiotics on treatment, investigating the relative impact of
to b-lactam antibiotics on cell survival in the presence of
antibiotics [22].
We have integrated cooperatively the different functional parts
of the bacterial cell in order to exert drug-resistance. In particular,
we have integrated the molecular information existing at the
various functional levels (genomics, transcriptomics, proteomics,
metabolomics) to model the whole mechanism essential to the
methicillin-resistance through a systems biology approach that
shows the behaviour of a single bacterial cell. In this context, a
systems biology approach can be useful to provide a framework, at
cellular level, able to define the timing as well as the hierarchy of
the metabolic reactions of drug resistance of S.aureus that is missing
in the literature.
Results
Description of the model
We created a model to simulate the mechanism of inactivation
of the PBP by methicillin, as well as the expression of PBP2a, the
regulation of the SCCmec elements (SCC: staphylococcal cassette
chromosome) [23], and the synthesis of peptidoglycan by PBP2a.
The model and the reaction equations for the model are shown in
Figure 2.
The peptidoglycan is obtained from the transpeptidation of NAM
and NAG groups (N-acetylmuramic acid and N-acetylglucosamine
repeats). In particular, the methicillin-resistance is not due to the
production of the b-lactamase enzyme, as one can see in the case of
the penicillin-resistance, but depends on the expression of a penicillin-
Figure 1.The methicillin structure.
doi:10.1371/journal.pone.0006226.g001
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some species. The frame in light violet represents the cellular membrane. B) Reactions and rate of the equations used in the model.
doi:10.1371/journal.pone.0006226.g002
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of the methicillin, as demonstrated by the low affinity of PBP2a for
the methicillin (METHICILLIN) [8,9]. In the chromosome of
methicillin-resistant strains was found the mecA_GENE, that express
PBP2a, and a series of other genes located on mobile genetic
elements, known as SCCmec elements. The mecR1_GENE encodes
a membrane-bound signal transduction protein (mecR1_PROTEIN)
while mecI_GENEencodes a transcriptional regulator (mecA_GEN-
E_repressor), which is a strong repressor of the expression of the
mecA gene. When MecR1 protein interacts with the methicillin, it
breaks off and its fragment (mecI_GENE_soppressor) is able to
repress the mecI_GENE. So, in the absence of the mecA_GEN-
E_soppressor, the mecA_GENE can express PBP2a. The PBP2a
expression enables the cell to synthesize the peptidoglycan and this
neutralizes the methicillin effect.
In the proposed model 11 reactions are involved. In particular,
Re1, Re2, Re6, Re7 and Re8, are defined as zeroth order forward,
first order reverse, reversible mass action kinetics; Re3 as second
order forward with two reactants, first order reverse, reversible
mass action kinetics (generalized mass-action); Re4 as first order
irreversible mass action kinetics; Re10 as first order irreversible
mass action kinetics (catalyzed by METHICILLIN); and Re9 and
Re11 as irreversible non modulated non-interacting bireactant
enzymes. (Appendix A, Table S1 and Table S2 in Supplementary
Material). Moreover, we modified the equation of the reaction
Re7 concerning the complex meticillin-mecRI concentration as
our variable, and we included in the equation of the reaction Re5
mecI_GENE_soppressor as our inhibitory variable.
The model presents the framework of genes, RNAs, enzymes,
products and reactions involved in the methicillin-resistence
phenomenon. In particular, it comprises 6 proteins, 3 genes, 3
RNAs, 1 drug, 2 generic-Molecule, 1 complex and 1 interaction
entity (Supplementary Table S2) and the following reactions: 2
state transitions, one of this catalysed by the meticillin drug, 3
associations, (2 of this catalysed by PBP and PBP2a enzymes), 2
transcriptional controls, 3 transcriptions and 3 traslations (Sup-
plementary Table S1 and Table S2).
Model simulations
This paper describes the results of an integrated approach to
model the phenomenon of resistance to methicillin in S. aureus at
molecular level. This should provide a basis for understanding the
dynamics involved in the cellular development of methicillin
resistance that can be able to develop pharmacological strategies to
overcome its resistance.
We have not used real concentrations for every molecular specie
because there are no experimental investigations that reported
quantitative data for a single cell. Nevertheless, literature studies
[23–25] follow us to determinate the relationships between the
species in the model and the framework between them was
established. We used for the constants (association, dissociation,
catalytic and inhibition) the values ranged between 0.1 and 2 (see
Supplementary Table S1) concerning the following biological
considerations. In details, the catalytic constant (kcat) may be
higher than that of association (kass) because it has a role speeding
the reaction but the association constant (kass) may be higher than
those of dissociation (kdiss) and inhibition (kini) having only a
regulatory and control role in the reaction in which these are
involved. In fact, when we used values out from 0.1,k,2 or from
the criteria reported above, the simulation produced wrong results:
i) negative concentrations for species if equal values were set for all
constants or if kass.kcat; ii) the meticillin effect was minimal if
kass,kdiss and iii) the peptidoglycan increase was slow if
kcat,kdiss and kcat,kass (Supplementary Figure S1).
All the molecular species are considered as variable species,
except the genes that are assumed constants because in a cell a
gene is always present, even if not expressed. When the
transcription is activated, the RNA is expressed and the variable
of the transcription process is the transcript amount, and not the
presence of the gene that can be activated or inactivated.
In absence of quantitative data regarding a single cell, we can
only assess the internal ratios existing among reactants or their
fluxes. Therefore, we refer to these in terms of amounts, to
evidence their presence or their absence. In particular, for the gene
class we can not define a concentration, assuming the gene as a
constant, and we set every one equal to an unit of amount. Some
amounts are fixed at zero because some species, as mecR1_drug,
mecI_GENE_soppressor, PBP2a, PBP_inactive, mecA_RNA,
initially are not expressed. MecR1_RNA is set equal to 1 as well
as the corresponding mec_R1_protein because these values
represent basal amounts to ensure the activation of the gene and
its relative expression. Instead, the peptidoglycan, PBP, NAM_-
peptide and NAG_peptide are initially set equal to 3 as amount
because in a synthesis process these species are more active respect
to mec_R1_protein being like a ‘‘sentinel’’ protein that attends
only when the methicillin arrives. MecA_GENE_soppressor and
mecI_RNA are set equal to 5 as amount. This is the highest value
because it represents the more important transcriptional control of
the bacterial resistance involved in the simulation. When PBP
enzymes are inactivated by the methicillin, PBP2a is expressed in
order to restart the synthesis of the peptidoglycan. In these
conditions it is observed a growing amount of various molecular
species involved in the mechanism of resistance, largely based on
the expression of PBP2a.
In the Figure 3a the variations of PBP, PBP-inactive and the
PBP2a are shown. The effect of the methicillin presence is evident
because PBP quickly decreases in about one unit of the simulation
time and becomes inactive (i.e. PBP-inactive), while the PBP2a is
slowly expressed in about seven units of the time scale. The
Figure 3b shows that 1) the methicillin amount decreases when it
interacts with the mecR1_PROTEIN and inactivates the PBP; 2)
the synthesis of peptidoglycan ends when PBPs are inactivated
while increases with the espression of PBP2a; 3) the amount of
mecR1_drug increases while the methicillin is consumed. It is
worthy of note that the total amount of mecR1_drug, spanning
from 0 to 6 time units, is about the 25–30% of the total methicillin.
This evaluation originates from the analysis of the graphs (see
Figure 3b) and is a consequence of the used parameters that were
not set on this criteria. In fact, as reported below, some initial
parameters were modified in order to verify how the curves change
and if the model reply in agreement to cellular mechanism.
However, this means that the methicillin affinity for its cellular
receptor (mecR) should be not very high.
This is in agreement to a recent article that has found the kinetic
data for the binding of penicillin-BlaR to be smaller in comparison
to other drugs [24]. Our simulations show that, while in the initial
phase of the methicillin action the PBPs are quickly inactivated,
the bacterial peptidoglycan growth are consistently reduced (about
55%) whereas the cell wall defence is quickly at the maximum in
the absence of methicillin.
In general, these results are consistent with the behaviour of the
methicillin-resistant S. aureus (MRSA) strains in presence of the
antibiotic methicillin but the model highlights new interesting
metabolic features of the cell reply. In particular, the whole
phenomenon is completely dependent from ‘‘de novo’’ biosynthe-
sis of peptidoglycan. The normal path to synthesize this structure is
rapidly inactivated by methicillin (see Figure 2). The new path, i.e.
the cellular response, occurs through the expression of PBP2a.
Bacterial Mechanism Modeling
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mechanisms have different kinetics. As shown in Figure 3b, the
inactivation of the normal path is immediate with the entrance of
methicillin, because it happens simply through the PBP inactiva-
tion. The cell reply depends on the mecR1_drug increase that is
related to the interaction between methicillin and mecR1_protein,
and is not directly linked to the total amount of methicillin, being
also used to inactivate PBP. This reply is also correlated to PBP2a
expression that needs a complete transcription, translation and
expression process. Therefore, the cellular response of defence is
slow compared to the action of the methicillin.
We have also perturbed our model with different methicillin
amounts to verify if it responds correctly to perturbations. In fact,
as one can easily control, the different concentrations of methicillin
modulate the cellular expression of PBP2a in proportion as well as
the peptidoglycan synthesis. In Figure 4 and Figure 5, we show the
results of different simulations.
In particular, the final amount of peptidoglycan is the same in
all conditions, being dictated by the need of the cell to synthesize
the wall protection. This agrees to the fact that the penicillin can
heavily attack the bacteria if they are in a growth stasis but if the
bacteria have lost their cell wall, they can grow and replicate in
presence of the antibiotic (L forms) that doesn’t appear toxic [25].
The kinetics of its synthesis depend on the presence of PBP and
PBP2a enzymes, and are strongly influenced by the amount of
methicillin, that induces their inactivation and expression, as we
shown in the Figure 4.
A large quantity of methicillin causes a rapid inactivation of the
PBP [9]. This induces a temporary stop of the peptidoglycan
synthesis that can be resumed only when the PBP2a expression,
being more slow respect to inactivation process, is completed.
Moreover, this result reveals an important period of latency that
can be used for new pharmacological approach. When the effect of
methicillin is poor, the process of inactivation is slower, and the
growth curve of peptidoglycan amount is not described by an
immediate stop but by a gradual decrease, that is followed by a
more rapid recovery of the growth, as shown in Figure 4. The
strong correlation between the amount of methicillin in the cell
and the rate of the phenomenon has been demonstrated
experimentally in infection models by the shorter, or absent,
post-antibiotic effects [26].
Furthermore, we focused our attention on the expression of
mecR1, in terms of gene, RNA and protein (Figure 5). The protein
mecR1 is the first involved in the detection of methicillin. This
protein activates the response of the cell after the drug binding. Our
simulation shows that, when the perturbation is due to a small
amount of methicillin, the cell is able to cover up quickly the right
amount of protein mecR1 with its concomitant transcription.
Instead, when the cell perturbation is due to a great amount of
methicillin, the transcription process to express mecR1 is not able to
immediately satisfy its consumption. This highlights the correlation
between the efficacy of the treatment and the doses used. Moreover,
we have also investigated the fluxes of all RNA species. The
simulations with different amount of methicillin (Figure 6) show that
the behaviour of RNA curves agrees with the biological expecta-
tions. In fact, in the absence of methicillin, mecA_RNA is not
expressed since it is not necessary to express PBP2a, but when
methicillin is assumed, both PBP2a and its related RNA are
expressed. As mentioned before (Figure 5), mecR1_RNA shows
different kinetics at different methicillin amounts because mecR1_-
protein is consumed and, consequently, the corresponding RNA
fluxes must change. In fact, mecR1_RNA is expressed only in the
absence of methicillin and it is consumed to inhibit PBP2a
expression. However, its amount can’t fall below a certain level to
maintain the inhibition. We have also verified that, with the
presence of methicillin, mecI_RNA falls below this threshold to stop
the inhibition as well as to allow the PBP2a expression.
Discussion
Our integrated approach shows that a computational model can
generate and describe correctly the whole phenomenon of the
methicillin resistance at biochemical level. The concept of
integrated biological system has emerged as a means of envisioning
how multifactorial biological processes operate as a whole. Here,
we attempted to evaluate the current state of knowledge about the
peptidoglycan components of MRSA wall in the context of
methicillin action. The model suggests that two metabolic
cascades, both activated by the methicillin, display strikingly
different levels of temporal response to varying strengths of
perturbations. In fact, the expression of the target gene
(mecI_gene) in the metabolic cascade was influenced by the
upstream reactions. This finding suggests that network connectiv-
ity has a greater effect on the variability of expression than the
expression of a gene itself. The model is able to accurately predict
the latency time of single genes within the two cascades
Figure 3. Simulation examples of our model. Flux curves obtained for PBP, PBP-inactive and PBP2a (a), peptidoglycan, METHICILLIN,
mecR1_drug (b). The substance amount and time are expressed in number of molecules and seconds, respectively.
doi:10.1371/journal.pone.0006226.g003
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quantitative manner.
Experimentally it’s known that, when the methicillin is assumed
by patients, PBP is inactivated but PBP2a is expressed and the
peptidoglycan synthesis is induced [8,9]. According to these data
the curves reported in Figure 3 showed that after methicillin
administration the PBP amount decreased while the PBP2a and
peptidoglycan amounts increased. Moreover, the model is also
able to react to the external perturbation (i.e. to different amounts
of methicillin) by activating the same biochemical mechanisms of
the S. aureus and modulating its response on the basis of the extent
of the perturbation. In fact, when the model is perturbed with
different amounts of methicillin, its reply is proportional to the
perturbation. The strong correlation between the amount of
methicillin in the cell and the rate of the phenomenon has also
been observed by the very short, or missing, post-antibiotic effects
(PAE) in experimental models of infection [26]. The ‘‘post-
antibiotic effect’’ term refers to the time period after complete
removal of an antibiotic during which there is no growth of the
target organism. This is a feature of most antibiotics agents
influenced by several factors, such as organism type, antibiotic
type, and treatment type. The beta-lactamic class has demon-
strated both in vivo and in vitro a post-antibiotic effect against gram-
positive cocci but not against gram-negative bacilli [26,27] because
of the structural complexity of the cell-wall of negative bacteria
which is opposed to the entry of the methicillin in the cytoplasmic
space. For this reason, the beta-lactamic treatment requires
frequent or continuous dosing.
The computational results demonstrate that the cellular
response depends on the effective amount of methicillin inside
the cell. Therefore, the knowledge of the integrated metabolic
behaviour can be useful to develop new therapeutic approaches to
control the methicillin resistance as well as a useful methodological
tool for deepening the understanding of the mechanism on the
cellular resistance to antibiotics. In fact, the time period between
the end of the path of the PBP inactivation and the activation of
the second path of the PBP2a expression corresponds to a latency
of the peptidoglycan biosynthesis. Visibly this is a period in which
the bacterium might be vulnerable. Moreover, the correlation
between the methicillin amount and the expression rate of some
proteins (see mecR1 in Figure 5) should also support a detailed
study of therapeutic doses.
In conclusion, our results show that the integrated approach of
the systems biology, that we have applied for studying the
Figure 4. Concentration curves of the various species: methicillin (black), peptidoglycan (violet), PBP (red), PBP2a (dark blue),
PBP_inactive (green), mecR1_drug (orange), in different simulations, using different METHICILLIN amounts: A: 3; B: 2.5; C: 2; D: 1,5;
E: 1; F: 0,5; G: 0. The various species are distinguished by colours as indicated in the legend. The substance amount and time are expressed in
number of molecules and seconds, respectively.
doi:10.1371/journal.pone.0006226.g004
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level, can be very useful to a biological modelling of complex
infectious diseases.
Methods
To develop models of integrated biochemical levels, it is
necessary to consider the mechanisms by which biochemical
information transfer occurs. The network of genes, mRNA,
proteins and metabolites was created using CellDesigner version
4.0 (http://celldesigner.org/), a software that enables users to
describe molecular interactions using a well-defined and consistent
graphical notation [28]. The data of molecular interactions are
stored in Systems Biology Markup Language (SBML; http://sbml.
org/) [29]. Since SBML is a standard machine-readable model
representation format, all the information can be used for a range
of computational analysis, including computer simulation [30].
To simulate the dynamic behavior of these biochemical
networks, kinetic equations have to be associated with each
reaction. The software SBMLsqueezer was used to generate
kinetic rate equations for our biochemical network. This approach
facilitates the modeling steps via automated generation of equation
and overcomes the highly error-prone and cumbersome process of
manually assigning kinetic equations. For each reaction the kinetic
equation is derived from the stoichiometry, the participating
species (e.g., proteins, mRNA or generic molecules) as well as the
regulatory relations (activation, inhibition or other modulations) of
the SBGN diagram. The software SBMLsqueezer offers different
types of kinetics (i.e. mass-action, Hill, and several Michaelis-
Menten-based kinetics), each including activation, inhibition and
reversibility or irreversibility for representing gene regulatory,
signal transduction, protein, metabolic, and mixed networks. The
rate laws were generated by considering for each reaction all
participating reactants, products and regulators. In particular, for
gene regulatory networks, i.e., transcriptional and translational
processes, the Hill equation is applied.
After invoking SBMLsqueezer, the kinetic formulas are
generated and assigned to the model, which was then simulated
in CellDesigner ver 4.0. Details on reaction type and differential
equations are reported in Figure 2B, Supplementary Appendix S1,
Table S1 and Table S2 and Supplementary Figure S2. Moreover,
the substance amount and time are expressed in number of
molecules and seconds, respectively (see for details Table 3 in
Hucka et al (2003) [31]).
Supporting Information
Appendix S1 Differential’s equations used in the model.
Found at: doi:10.1371/journal.pone.0006226.s001 (0.18 MB
DOC)
Figure 5. Concentration curves of the various species: methicillin (black), all genes (green), mecR1_protein (blue), mecR1_RNA
(red), in different simulations, using different METHICILLIN amounts: A: 3; B: 2.5; C: 2; D: 1,5; E: 1; F: 0,5; G: 0. The various species are
distinguished by colours as indicated in the legend. The substance amount and time are expressed in number of molecules and seconds, respectively.
doi:10.1371/journal.pone.0006226.g005
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constants are fixed as indicated for the final model, b) all the
constants are set equal to 1, c) all the dissociation constants are set
equal to 4, being higher than the association constant, d) all the
catalytic constants are set equal to 0.1, being lower than the
association constant, e) all the association constants are set equal to
0.1, being lower than the dissociation constant, f) one of the
association constants is set equal to 4, being out from the
established range. The substance amount and time are expressed
in number of molecules and seconds, respectively.
Found at: doi:10.1371/journal.pone.0006226.s002 (0.43 MB
DOC)
Figure S2 Graphical notations and colors used to represent the
network (CellDesigner ver4.0).
Found at: doi:10.1371/journal.pone.0006226.s003 (0.04 MB
DOC)
Table S1 Details regarding the reactions type and the names
used to indicate both reactants and products and the parameters
values.
Found at: doi:10.1371/journal.pone.0006226.s004 (0.04 MB
DOC)
Table S2 Details on initial quantities of all species used during
the simulation.
Found at: doi:10.1371/journal.pone.0006226.s005 (0.05 MB
DOC)
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